SCHEMBL28124182

SCHEMBL28124182

CCON(C)C1CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.48
DDB1 Q16531 1/20 0.46
CRBN Q96SW2 1/20 0.46
USP30 Q70CQ3 2/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
JAK1 P23458 2/20 0.39
JAK2 O60674 1/20 0.39
GPR119 Q8TDV5 2/20 0.38
NAMPT P43490 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
HPGD P15428 1/20 0.37
TACR1 P25103 1/20 0.36
HSD11B1 P28845 1/20 0.36
KDM4E B2RXH2 1/20 0.36
JAK3 P52333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28124791 0.85 GPR119 (0.49) USP30USP2SMN1; SMN2GPR119MEN1
SCHEMBL21641106 0.82 DDB1 (0.49) NR1H2DDB1CRBNUSP30USP2
SCHEMBL14697592 0.81 NR1H2 (0.50) NR1H2DDB1CRBNUSP30USP2
SCHEMBL3563885 0.80 DDB1 (0.52) NR1H2DDB1CRBNUSP30USP2
SCHEMBL24161826 0.79 NR1H2 (0.51) NR1H2DDB1CRBNUSP30USP2
SCHEMBL24027370 0.78 NR1H2 (0.48) NR1H2DDB1CRBNUSP30USP2
SCHEMBL28124192 0.77 NR1H2 (0.42) NR1H2DDB1CRBNUSP30USP2
SCHEMBL21966137 0.77 DDB1 (0.50) NR1H2DDB1CRBNUSP30USP2
SCHEMBL19441802 0.77 DDB1 (0.50) NR1H2DDB1CRBNUSP30USP2
SCHEMBL22989452 0.76 NR1H2 (0.49) NR1H2DDB1CRBNUSP30USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459034-B Carbostyril derivative as fibroblast growth factor acceptor inhibitor 普林斯匹亚生物制药公司 2018-01-12 CN disclosed
CN-106459034-A Quinolone derivatives as fibroblast growth factor receptor inhibitors 普林斯匹亚生物制药公司 2017-02-22 CN disclosed